CLDN3 and prostate cancer: In addition, treatment with rVP1 caused apoptosis in three cancer cell lines: the breast carcinoma cell line MCF-7, the androgen-independent prostate cancer cell line PC-3, and the androgen-dependent prostate cancer cell line 22Rv1 [13].